Moonwalk Bio

adipose biology, epigenetic engineering, siRNA

editingrna therapeutic

moonwalk.bio·South San Francisco, California, United States·$57M total funding

Plate C · C-XG0J

Projects

exploratory

platform · high · Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Enable next-generation multiplex epigenetic engineering for therapeutic discovery and development.

Platform technologies named EpiRead and EpiWrite for reading and writing epigenetic states in multiplex format.

Moonwalk announced it would present data showcasing EpiRead and EpiWrite at ASGCT 2024.

Public record states data were to be presented, but the supplied material does not include the data outcomes.

exploratory

research program · medium

Discover and develop therapeutics in adipose biology informed by deep genetic and epigenetic insights.

Research program combining adipose biology, genetics, epigenetics, and Moonwalk's epigenetic engineering platform.

Company site analysis describes Moonwalk as developing therapeutics in adipose biology and highlights its platform and R&D team.

preclinical

drug program · medium

Develop obesity therapies focused on adipose biology using genetic and epigenetic insights.

siRNA-based therapeutic approach applied to adipose biology targets.

Company site analysis notes a recent focus on siRNA obesity therapies and lists a pipeline page.

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence